Literature DB >> 20423334

Signal transduction by protease-activated receptors.

Unice J K Soh1, Michael R Dores, Buxin Chen, JoAnn Trejo.   

Abstract

The family of G protein-coupled receptors (GPCRs) constitutes the largest class of signalling receptors in the human genome, controlling vast physiological responses and are the target of many drugs. After activation, GPCRs are rapidly desensitized by phosphorylation and beta-arrestin binding. Most classic GPCRs are internalized through a clathrin, dynamin and beta-arrestin-dependent pathway and then recycled back to the cell surface or sorted to lysosomes for degradation. Given the vast number and diversity of GPCRs, different mechanisms are likely to exist to precisely regulate the magnitude, duration and spatial aspects of receptor signalling. The G protein-coupled protease-activated receptors (PARs) provide elegant examples of GPCRs that are regulated by distinct desensitization and endocytic sorting mechanisms, processes that are critically important for the spatial and temporal fidelity of PAR signalling. PARs are irreversibly activated through proteolytic cleavage and transmit cellular responses to extracellular proteases. Activated PAR(1) internalizes through a clathrin- and dynamin-dependent pathway independent of beta-arrestins. Interestingly, PAR(1) is basally ubiquitinated and deubiquitinated after activation and traffics from endosomes to lysosomes independent of ubiquitination. In contrast, beta-arrestins mediate activated PAR(2) internalization and function as scaffolds that promote signalling from endocytic vesicles. Moreover, activated PAR(2) is modified with ubiquitin, which facilitates lysosomal degradation. Activated PARs also adopt distinct active conformations that signal to diverse effectors and are likely regulated by different mechanisms. Thus, the identification of the molecular machinery important for PAR signal regulation will enable the development of new strategies to manipulate receptor signalling and will provide novel targets for the development of drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20423334      PMCID: PMC2874842          DOI: 10.1111/j.1476-5381.2010.00705.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  115 in total

1.  Desensitization of the isolated beta 2-adrenergic receptor by beta-adrenergic receptor kinase, cAMP-dependent protein kinase, and protein kinase C occurs via distinct molecular mechanisms.

Authors:  J Pitcher; M J Lohse; J Codina; M G Caron; R J Lefkowitz
Journal:  Biochemistry       Date:  1992-03-31       Impact factor: 3.162

2.  Activated protein C variants with normal cytoprotective but reduced anticoagulant activity.

Authors:  Laurent O Mosnier; Andrew J Gale; Subramanian Yegneswaran; John H Griffin
Journal:  Blood       Date:  2004-06-03       Impact factor: 22.113

3.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

Authors:  T K Vu; D T Hung; V I Wheaton; S R Coughlin
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

4.  Domains specifying thrombin-receptor interaction.

Authors:  T K Vu; V I Wheaton; D T Hung; I Charo; S R Coughlin
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

5.  beta-Arrestin: a protein that regulates beta-adrenergic receptor function.

Authors:  M J Lohse; J L Benovic; J Codina; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1990-06-22       Impact factor: 47.728

Review 6.  The role of receptor kinases and arrestins in G protein-coupled receptor regulation.

Authors:  J G Krupnick; J L Benovic
Journal:  Annu Rev Pharmacol Toxicol       Date:  1998       Impact factor: 13.820

7.  Sorting nexin-1 mediates tubular endosome-to-TGN transport through coincidence sensing of high- curvature membranes and 3-phosphoinositides.

Authors:  Jez Carlton; Miriam Bujny; Brian J Peter; Viola M J Oorschot; Anna Rutherford; Harry Mellor; Judith Klumperman; Harvey T McMahon; Peter J Cullen
Journal:  Curr Biol       Date:  2004-10-26       Impact factor: 10.834

8.  Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function.

Authors:  R M Scarborough; M A Naughton; W Teng; D T Hung; J Rose; T K Vu; V I Wheaton; C W Turck; S R Coughlin
Journal:  J Biol Chem       Date:  1992-07-05       Impact factor: 5.157

9.  Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation.

Authors:  Dalila Darmoul; Valérie Gratio; Hélène Devaud; Marc Laburthe
Journal:  J Biol Chem       Date:  2004-03-09       Impact factor: 5.157

10.  A tyrosine-based sorting signal regulates intracellular trafficking of protease-activated receptor-1: multiple regulatory mechanisms for agonist-induced G protein-coupled receptor internalization.

Authors:  May M Paing; Brenda R S Temple; JoAnn Trejo
Journal:  J Biol Chem       Date:  2004-03-15       Impact factor: 5.157

View more
  119 in total

1.  Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets.

Authors:  Paul A Lapchak; Qiang Wu
Journal:  J Neurol Neurophysiol       Date:  2011

Review 2.  Protein degradation and memory formation.

Authors:  Diasynou Fioravante; John H Byrne
Journal:  Brain Res Bull       Date:  2010-11-13       Impact factor: 4.077

3.  Featured Article: Differential regulation of endothelial nitric oxide synthase phosphorylation by protease-activated receptors in adult human endothelial cells.

Authors:  Lakeisha C Tillery; Tenille A Epperson; Satoru Eguchi; Evangeline D Motley
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-04

4.  Construction of a cell model of β2-adrenoceptor downregulation.

Authors:  Hua Liu; Yun Chen; Jun Li; Weishuai Zhang; Songshi Ni
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

5.  Neutrophil elastase contributes to the pathological vascular permeability characteristic of diabetic retinopathy.

Authors:  Haitao Liu; Emma M Lessieur; Aicha Saadane; Sarah I Lindstrom; Patricia R Taylor; Timothy S Kern
Journal:  Diabetologia       Date:  2019-10-14       Impact factor: 10.122

Review 6.  Role of the blood coagulation cascade in hepatic fibrosis.

Authors:  Asmita Pant; Anna K Kopec; James P Luyendyk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-05-03       Impact factor: 4.052

Review 7.  Itch mechanisms and circuits.

Authors:  Liang Han; Xinzhong Dong
Journal:  Annu Rev Biophys       Date:  2014       Impact factor: 12.981

8.  Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer's diseases.

Authors:  Daruoosh Zare; Mohammad Amin Rajizadeh; Marzieh Maneshian; Hossein Jonaidi; Vahid Sheibani; Majid Asadi-Shekaari; Manouchehr Yousefi; Khadijeh Esmaeilpour
Journal:  Psychopharmacology (Berl)       Date:  2021-02-23       Impact factor: 4.530

9.  Palmitoylation of protease-activated receptor-1 regulates adaptor protein complex-2 and -3 interaction with tyrosine-based motifs and endocytic sorting.

Authors:  Isabel Canto; JoAnn Trejo
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

10.  Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (CXC motif) receptor 4.

Authors:  Xianlong Gao; You-Hong Cheng; Garrett A Enten; Anthony J DeSantis; Vadim Gaponenko; Matthias Majetschak
Journal:  J Biol Chem       Date:  2020-08-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.